Fundraising Fox
/Companies
Sign in

Kite Pharma

Santa Monica, US · Founded 2009 · 2 known investors

Find your way into Kite Pharma

355 people in our graph share verified history with the Kite Pharma team — schools, employers, funds. One of them is your warm intro.

Chris Peetzunlockedknows Marc Better · together at Abgenix (overlapped)
×2knows the team · via NextWave Pharmaceuticals Inc.
knows the team · via Abgenix
×8knows the team · via Amgen

Kite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.

BiotechHealthtech

Founders & leadership

Kite Pharma was founded in 2009 by Arie S. Belldegrun.

ASArie S. Belldegrun
Arie S. BelldegrunFounder · ChairmanformerFounder and Senior Managing Director at Vida Ventures
MR
Margo R. RobertsExecutive
CBCynthia Butitta
Cynthia ButittaExecutiveCynthia Butitta is an executive with over 25 years of experience in biotechnology and high technology, spanning roles in both early-stage and Fortune 100 companies. Her background includes mergers and acquisitions, IPO preparation, strategic planning, and operations management.
MBMarc Better
Marc BetterExecutiveMarc Better is an Executive Officer at Kite Pharma with more than 25 years of experience in cell therapy and biologics development, including upstream and downstream process development, GMP manufacturing, quality oversight, and regulatory interactions across cell therapy and biologics programs.
RS
Rizwana SprouleExecutive

Board

JA
Joshua A. KazamBoard director
DB
David BondermanBoard director
FCFarah Champsi
Farah ChampsiBoard directorVenture Advisor at Agent Capital
RNRan Nussbaum
Ran NussbaumBoard directorManaging Partner at Pontifax Venture Capital
SB
Steven B. RuchefskyBoard director
RD
Roy DoumaniBoard director
JM
Jonathan M. PeacockBoard director

Investors · 2

Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya · $6.3M – $128M

How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$50M disclosed across 1 of 2 rounds · 2014–2025

▶$50MraisedMay 2014 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roy DoumaniDirector
  • Joshua A. KazamDirector
  • Margo R. RobertsExecutive Officer
  • Cynthia ButittaExecutive Officer
  • David BondermanDirector
  • Jonathan M. PeacockDirector
  • Arie S. BelldegrunExecutive Officer, Director
  • Marc BetterExecutive Officer
  • Farah ChampsiDirector
  • Ran NussbaumDirector
  • Steven B. RuchefskyDirector
  • Rizwana SprouleExecutive Officer
  • Keith NolopExecutive Officer
Offering amount
$50M
Amount sold
$50M
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Kite Pharma went on to found or lead other companies.

Peter EmtageGlobal Head of Cell Therapy ResearchFounded Santa AnaRan NussbaumDirectorFounded Pontifax

Frequently asked questions

What does Kite Pharma do?
Kite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Who founded Kite Pharma?
Kite Pharma was founded by Arie S. Belldegrun in 2009.
Who are Kite Pharma's investors?
Kite Pharma's investors include Alta Partners, Pontifax Venture Capital.
How much funding has Kite Pharma raised?
Kite Pharma has disclosed $50M raised across 1 of its 2 known rounds.
Where is Kite Pharma headquartered?
Kite Pharma is headquartered in Santa Monica, US.